home / stock / cmps / cmps news


CMPS News and Press, COMPASS Pathways Plc From 06/20/24

Stock Information

Company Name: COMPASS Pathways Plc
Stock Symbol: CMPS
Market: NASDAQ
Website: compasspathways.com

Menu

CMPS CMPS Quote CMPS Short CMPS News CMPS Articles CMPS Message Board
Get CMPS Alerts

News, Short Squeeze, Breakout and More Instantly...

CMPS - (CMPS) On The My Stocks Page

2024-06-20 15:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

CMPS - UC Berkeley Research to Investigate How Psychedelics Alter People's Views

Psychedelic fungi and plants have been used by various Indigenous communities in their healing and spiritual ceremonies for millennia. In the 1950s and 1960s, western therapists, psychiatrists and researchers began looking into whether these drugs could be used to manage mental-health condition...

CMPS - Should You Buy the Dip on Compass Pathways Stock?

2024-06-12 06:25:00 ET If you can do the mental work to separate your sentiment about a stock from its recent price action, buying the dip in a recently dented winner can be a profitable investing strategy. Of course, it's key that you determine whether a business is experiencing a temporar...

CMPS - (CMPS) Investment Analysis

2024-06-10 16:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

CMPS - Case Study Documents Psychedelics Aiding Patient's Recovery from Long-COVID

Long-COVID , also referred to as post-acute sequelae of SARS-CoV-2 infection, includes various symptoms that persist even after an individual recovers from the COVID-19. These symptoms include cognitive impairment, fatigue, depression, anxiety, headaches and joint pain. Currently, effective tre...

CMPS - Wall Street Lunch: Not An Ecstatic Day

2024-06-05 14:37:06 ET Summary Shares of psychedelic medicine developers fall after the FDA panel votes against approving MDMA for PTSD treatment. U.S. private sector job growth falls short of expectations, raising concerns about the labor market. Wells Fargo's Chris Harvey co...

CMPS - Psychedelic stocks fall as FDA panel rejects MDMA therapy

2024-06-05 07:17:36 ET More on ATAI, COMPASS Pathways, etc. ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Biggest stock...

CMPS - FDA advisory panel fails to endorse psychedelic MDMA therapy for PTSD

2024-06-04 17:32:04 ET More on psychedelic drug companies ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Psychedelic sto...

CMPS - Psychedelic stocks mixed as FDA comments on MDMA therapy

2024-05-31 10:43:44 ET More on ATAI, COMPASS Pathways, etc. ATAI: Enormous Potential Upside But No Clarity Yet Psychedelics Closer To Commercialization; Compass Far And Away The Leader COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript Mind Medicine...

CMPS - Psychedelics Closer To Commercialization; Compass Far And Away The Leader

2024-05-23 12:15:00 ET Summary Regulatory risk in the psychedelic industry is decreasing, which is a positive sign for investors. Institutional investors are becoming more willing to invest in leading psychedelic companies through private placements. Analyst Alex Carchidi disc...

Previous 10 Next 10